Hypertriglyceridemia and cardiovascular diseases: Revisited

Seung Hwan Han, Stephen J. Nicholls, Ichiro Sakuma, Dong Zhao, Kwang Kon Koh

Research output: Contribution to journalReview articlepeer-review

27 Citations (Scopus)


Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting hypertriglyceridemia. Hypertriglyceridemia, triglyceride-rich lipoproteins, and remnant cholesterol have demonstrated to be important risk factors for cardiovascular disease; this has been demonstrated in experimental, genetic, and epidemiological studies. Fibrates can reduce cardiovascular event rates with or without statins. High dose omega-3 fatty acids continue to be evaluated and new specialized targeting treatment modulating triglyceride pathways, such as inhibition of apolipoprotein C-III and angiopoietin-like proteins, are being tested with regard to their effects on lipid profiles and cardiovascular outcomes. In this review, we will discuss the role of hypertriglyceridemia, triglyceride-rich lipoproteins and remnant cholesterol on cardiovascular disease, and the potential implications for treatment stargeting hypertriglyceridemia.

Original languageEnglish
Pages (from-to)135-144
Number of pages10
JournalKorean Circulation Journal
Issue number2
Publication statusPublished or Issued - Mar 2016


  • Cardiovascular disease
  • Hypertriglyceridemia
  • Residual cardiovascular risk
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this